Engineered peptides and proteins have revolutionized how scientific researchers interrogate biology and how clinicians treat disease.
Over the last couple of decades, chemists and biologists have developed new ways to modify peptides and proteins that can improve their specificity, enable switchability, and enhance their pharmacological properties.
The Chemical Biology: Peptide and Protein Design conference will explore the latest research on “designer” peptides and proteins, and how chemists and biologists alike are using these specialized biomolecules as tools to understand biological mechanisms and as therapeutics to treat human disease.
This program highlights keynote speaker Sam Gellman, PhD, from the University of Wisconsin-Madison, as well as plenary presentations from both academic and industry researchers. Together, these talks will explore topics such as therapeutics inspired by nature, high-throughput viral display, and non-traditional strategies for targeting oncogenic signaling pathways. In addition, a selection of early-career researchers will have the opportunity to share their innovative work in peptide and protein design through short talks and poster presentations.